PATENT CLAIM ANALYSIS

Application Number: 15862934
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to nucleic acids and antibodies against SRPX2 and SRPX2 protein function in angiogenesis. Angiogenesis-related conditions, such as cancer or wound healing, can be treated by the composition comprising the SRPX2 antagonists or agonists, respectively.

Claim (Index 9):
An antibody or a fragment thereof that binds to an SRPX2 amino acid sequence selected from SEQ ID NOs: 14-23 and inhibits the activity of SRPX2 in angiogenesis.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.22857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13557660', '14158463', '10569744', '13229866', '14185842']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7624209281683383
- 35 USC 102 Novelty (BERT): 0.53003455826015
- Combined Prediction Score: 0.7391822911775194
- Mean Citation Score: 300.343718
- Max Citation Score: 350.86752
- Similarity Product: 244.1703464722252

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test